I study the effects of the protein, GABPβ1L, on regulation of the mutant TERT promoter, and its impact on cell immortality. I am exploring a therapeutic approach in glioblastoma patient-derived cell cultures to specifically target the mutant TERT promoter, which should limit effects on non-cancerous cells.

- Eight years of research experience in molecular biology and functional genomics

- Expertise in NGS assay development and optimization, as well as NGS data generation, including sample preparation, library generation, and operating Illumina sequencers

- Expertise in SNP biology, genetic regulatory mechanisms, and pre-clinical experiments

- High impact publication record: Cancer Cell; Journal of Neuro-Oncology; Molecular Cancer Research